CLSN's price/sales ratio is 67.35; that's higher than the P/S ratio of 95.53% of US stocks.
In terms of volatility of its share price, CLSN is more volatile than 98.12% of stocks we're observing.
Celsion CORP's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -81.64%, greater than the shareholder yield of merely 3.37% of stocks in our set.
Stocks with similar financial metrics, market capitalization, and price volatility to Celsion CORP are RGLS, XFOR, ARDX, RMBS, and PTCT.
Celsion Corporation focuses on the development and commercialization of directed chemotherapy, DNA-mediated immunotherapy, and RNA based therapy products for the treatment of cancer. The company was founded in 1982 and is based in Lawrenceville, New Jersey.
LOS ANGELES, CA / ACCESSWIRE / December 29, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Celsion Corporation ("Celsion" or "the Company") (NASDAQ:CLSN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.
NEW YORK, NY / ACCESSSWIRE / December 29, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Celsion Corporation("Celsion" or "the Company") (NASDAQ:CLSN) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Celsion securities between November 2, 2015 to July 10, 2020, both dates inclusive (the "Class Period").
NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Celsion Corporation (NASDAQ: CLSN) between November 2, 2015 and July 10, 2020, inclusive (the “Class Period”), of the important December 29, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Celsion investors under the federal securities laws. To join the Celsion class action, go to http://www.rosenlegal.com/cases-register-1978.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose th...
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Celsion Corporation ("Celsion" or "the Company") (NASDAQ: CLSN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.